경피 피부 패치 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2023-2031년)

Transdermal Skin Patches Market - Scope of Report

TMR's report on the global transdermal skin patches market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global transdermal skin patches market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global transdermal skin patches market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the transdermal skin patches market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global transdermal skin patches market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global transdermal skin patches market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global transdermal skin patches market.

The report delves into the competitive landscape of the global transdermal skin patches market. Key players operating in the global transdermal skin patches market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global transdermal skin patches market profiled in this report.

Key Questions Answered in Global Transdermal Skin Patches Market Report:

• What is the sales/revenue generated by transdermal skin patches across all regions during the forecast period?
• What are the opportunities in the global transdermal skin patches market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Transdermal Skin Patches Market - Research Objectives and Research Approach

The comprehensive report on the global transdermal skin patches market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global transdermal skin patches market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global transdermal skin patches market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Transdermal Skin Patches Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Product Definition
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Transdermal Skin Patches Market Analysis and Forecast, 2017 - 2031
  • 4.4.1. Market Revenue Projection (US$ Bn)

5. Key Insights

• 5.1. Regulatory Scenario by Region/Globally
• 5.2. Disease Prevalence & Incidence Rate Globally with Key Countries
• 5.3. Pipeline Analysis
• 5.4. Key Product/brand Analysis
• 5.5. COVID-19 Impact on the Industry

6. Global Transdermal Skin Patches Market Analysis and Forecast, By Product Type

• 6.1. Introduction & Definition
• 6.2. Key Findings / Developments
• 6.3. Market Value Forecast By Product Type, 2017 - 2031
  • 6.3.1. Reservoir
  • 6.3.2. Drug-in-Adhesive
    • 6.3.2.1. Single Layer
    • 6.3.2.2. Multilayer
  • 6.3.3. Microneedle
  • 6.3.4. Matrix
  • 6.3.5. Others (Vapor, etc.)
• 6.4. Market Attractiveness By Product Type

7. Global Transdermal Skin Patches Market Analysis and Forecast, By Application

• 7.1. Introduction & Definition
• 7.2. Key Findings / Developments
• 7.3. Market Value Forecast By Application, 2017 - 2031
  • 7.3.1. Pain Management
  • 7.3.2. Hormonal Disorders
  • 7.3.3. Smoking Reduction and Cessation Aid
  • 7.3.4. Neurological Disorders
  • 7.3.5. Cardiovascular Disorders
  • 7.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
• 7.4. Market Attractiveness By Application

8. Global Transdermal Skin Patches Market Analysis and Forecast, By Sales Type

• 8.1. Introduction & Definition
• 8.2. Key Findings / Developments
• 8.3. Market Value Forecast By Sales Type, 2017 - 2031
  • 8.3.1. Prescription
  • 8.3.2. Over-the-Counter (OTC)
• 8.4. Market Attractiveness By Sales Type

9. Global Transdermal Skin Patches Market Analysis and Forecast, By Distribution Channel

• 9.1. Introduction & Definition
• 9.2. Key Findings / Developments
• 9.3. Market Value Forecast By Distribution Channel, 2017 - 2031
  • 9.3.1. Hospital Pharmacies
  • 9.3.2. Retail Pharmacies
  • 9.3.3. Online Pharmacies
• 9.4. Market Attractiveness By Distribution Channel

10. Global Transdermal Skin Patches Market Analysis and Forecast, By Region

• 10.1. Key Findings
• 10.2. Market Value Forecast By Region
  • 10.2.1. North America
  • 10.2.2. Europe
  • 10.2.3. Asia Pacific
  • 10.2.4. Latin America
  • 10.2.5. Middle East & Africa
• 10.3. Market Attractiveness By Country/Region

11. North America Transdermal Skin Patches Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast By Product Type, 2017 - 2031
  • 11.2.1. Reservoir
  • 11.2.2. Drug-in-Adhesive
    • 11.2.2.1. Single Layer
    • 11.2.2.2. Multilayer
  • 11.2.3. Microneedle
  • 11.2.4. Matrix
  • 11.2.5. Others (Vapor, etc.)
• 11.3. Market Value Forecast By Application, 2017 - 2031
  • 11.3.1. Pain Management
  • 11.3.2. Hormonal Disorders
  • 11.3.3. Smoking Reduction and Cessation Aid
  • 11.3.4. Neurological Disorders
  • 11.3.5. Cardiovascular Disorders
  • 11.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
• 11.4. Market Value Forecast By Sales Type, 2017 - 2031
  • 11.4.1. Prescription
  • 11.4.2. Over-the-Counter (OTC)
• 11.5. Market Value Forecast By Distribution Channel, 2017 - 2031
  • 11.5.1. Hospital Pharmacies
  • 11.5.2. Retail Pharmacies
  • 11.5.3. Online Pharmacies
• 11.6. Market Value Forecast By Country, 2017 - 2031
  • 11.6.1. U.S.
  • 11.6.2. Canada
• 11.7. Market Attractiveness Analysis
  • 11.7.1. By Product Type
  • 11.7.2. By Application
  • 11.7.3. By Sales Type
  • 11.7.4. By Distribution Channel
  • 11.7.5. By Country

12. Europe Transdermal Skin Patches Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast By Product Type, 2017 - 2031
  • 12.2.1. Reservoir
  • 12.2.2. Drug-in-Adhesive
    • 12.2.2.1. Single Layer
    • 12.2.2.2. Multilayer
  • 12.2.3. Microneedle
  • 12.2.4. Matrix
  • 12.2.5. Others (Vapor, etc.)
• 12.3. Market Value Forecast By Application, 2017 - 2031
  • 12.3.1. Pain Management
  • 12.3.2. Hormonal Disorders
  • 12.3.3. Smoking Reduction and Cessation Aid
  • 12.3.4. Neurological Disorders
  • 12.3.5. Cardiovascular Disorders
  • 12.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
• 12.4. Market Value Forecast By Sales Type, 2017 - 2031
  • 12.4.1. Prescription
  • 12.4.2. Over-the-Counter (OTC)
• 12.5. Market Value Forecast By Distribution Channel, 2017 - 2031
  • 12.5.1. Hospital Pharmacies
  • 12.5.2. Retail Pharmacies
  • 12.5.3. Online Pharmacies
• 12.6. Market Value Forecast By Country, 2017 - 2031
  • 12.6.1. Germany
  • 12.6.2. U.K.
  • 12.6.3. France
  • 12.6.4. Italy
  • 12.6.5. Spain
  • 12.6.6. Rest of Europe
• 12.7. Market Attractiveness Analysis
  • 12.7.1. By Product Type
  • 12.7.2. By Application
  • 12.7.3. By Sales Type
  • 12.7.4. By Distribution Channel
  • 12.7.5. By Country

13. Asia Pacific Transdermal Skin Patches Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast By Product Type, 2017 - 2031
  • 13.2.1. Reservoir
  • 13.2.2. Drug-in-Adhesive
    • 13.2.2.1. Single Layer
    • 13.2.2.2. Multilayer
  • 13.2.3. Microneedle
  • 13.2.4. Matrix
  • 13.2.5. Others (Vapor, etc.)
• 13.3. Market Value Forecast By Application, 2017 - 2031
  • 13.3.1. Pain Management
  • 13.3.2. Hormonal Disorders
  • 13.3.3. Smoking Reduction and Cessation Aid
  • 13.3.4. Neurological Disorders
  • 13.3.5. Cardiovascular Disorders
  • 13.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
• 13.4. Market Value Forecast By Sales Type, 2017 - 2031
  • 13.4.1. Prescription
  • 13.4.2. Over-the-Counter (OTC)
• 13.5. Market Value Forecast By Distribution Channel, 2017 - 2031
  • 13.5.1. Hospital Pharmacies
  • 13.5.2. Retail Pharmacies
  • 13.5.3. Online Pharmacies
• 13.6. Market Value Forecast By Country, 2017 - 2031
  • 13.6.1. Japan
  • 13.6.2. China
  • 13.6.3. India
  • 13.6.4. Australia & New Zealand
  • 13.6.5. Rest of Asia Pacific
• 13.7. Market Attractiveness Analysis
  • 13.7.1. By Product Type
  • 13.7.2. By Application
  • 13.7.3. By Sales Type
  • 13.7.4. By Distribution Channel
  • 13.7.5. By Country

14. Latin America Transdermal Skin Patches Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast By Product Type, 2017 - 2031
  • 14.2.1. Reservoir
  • 14.2.2. Drug-in-Adhesive
    • 14.2.2.1. Single Layer
    • 14.2.2.2. Multilayer
  • 14.2.3. Microneedle
  • 14.2.4. Matrix
  • 14.2.5. Others (Vapor, etc.)
• 14.3. Market Value Forecast By Application, 2017 - 2031
  • 14.3.1. Pain Management
  • 14.3.2. Hormonal Disorders
  • 14.3.3. Smoking Reduction and Cessation Aid
  • 14.3.4. Neurological Disorders
  • 14.3.5. Cardiovascular Disorders
  • 14.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
• 14.4. Market Value Forecast By Sales Type, 2017 - 2031
  • 14.4.1. Prescription
  • 14.4.2. Over-the-Counter (OTC)
• 14.5. Market Value Forecast By Distribution Channel, 2017 - 2031
  • 14.5.1. Hospital Pharmacies
  • 14.5.2. Retail Pharmacies
  • 14.5.3. Online Pharmacies
• 14.6. Market Value Forecast By Country, 2017 - 2031
  • 14.6.1. Brazil
  • 14.6.2. Mexico
  • 14.6.3. Rest of Latin America
• 14.7. Market Attractiveness Analysis
  • 14.7.1. By Product Type
  • 14.7.2. By Application
  • 14.7.3. By Sales Type
  • 14.7.4. By Distribution Channel
  • 14.7.5. By Country

15. Middle East & Africa Transdermal Skin Patches Market Analysis and Forecast

• 15.1. Introduction
  • 15.1.1. Key Findings
• 15.2. Market Value Forecast By Product Type, 2017 - 2031
  • 15.2.1. Reservoir
  • 15.2.2. Drug-in-Adhesive
    • 15.2.2.1. Single Layer
    • 15.2.2.2. Multilayer
  • 15.2.3. Microneedle
  • 15.2.4. Matrix
  • 15.2.5. Others (Vapor, etc.)
• 15.3. Market Value Forecast By Application, 2017 - 2031
  • 15.3.1. Pain Management
  • 15.3.2. Hormonal Disorders
  • 15.3.3. Smoking Reduction and Cessation Aid
  • 15.3.4. Neurological Disorders
  • 15.3.5. Cardiovascular Disorders
  • 15.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
• 15.4. Market Value Forecast By Sales Type, 2017 - 2031
  • 15.4.1. Prescription
  • 15.4.2. Over-the-Counter (OTC)
• 15.5. Market Value Forecast By Distribution Channel, 2017 - 2031
  • 15.5.1. Hospital Pharmacies
  • 15.5.2. Retail Pharmacies
  • 15.5.3. Online Pharmacies
• 15.6. Market Value Forecast By Country, 2017 - 2031
  • 15.6.1. GCC Countries
  • 15.6.2. South Africa
  • 15.6.3. Rest of the Middle East & Africa
• 15.7. Market Attractiveness Analysis
  • 15.7.1. By Product Type
  • 15.7.2. By Application
  • 15.7.3. By Sales Type
  • 15.7.4. By Distribution Channel
  • 15.7.5. By Country

16. Competition Landscape

• 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
• 16.2. Market Share Analysis By Company (2022)
• 16.3. Company Profiles
  • 16.3.1. Hisamitsu Pharmaceutical Co., Inc.
    • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.1.2. Product Portfolio
    • 16.3.1.3. Financial Overview
    • 16.3.1.4. SWOT Analysis
    • 16.3.1.5. Strategic Overview
  • 16.3.2. Viatris Inc.
    • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.2.2. Product Portfolio
    • 16.3.2.3. Financial Overview
    • 16.3.2.4. SWOT Analysis
    • 16.3.2.5. Strategic Overview
  • 16.3.3. Nitto Denko Corporation
    • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.3.2. Product Portfolio
    • 16.3.3.3. Financial Overview
    • 16.3.3.4. SWOT Analysis
    • 16.3.3.5. Strategic Overview
  • 16.3.4. Novartis AG
    • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.4.2. Product Portfolio
    • 16.3.4.3. Financial Overview
    • 16.3.4.4. SWOT Analysis
    • 16.3.4.5. Strategic Overview
  • 16.3.5. Luye Pharma Group
    • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.5.2. Product Portfolio
    • 16.3.5.3. Financial Overview
    • 16.3.5.4. SWOT Analysis
    • 16.3.5.5. Strategic Overview
  • 16.3.6. Teikoku Pharma
    • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.6.2. Product Portfolio
    • 16.3.6.3. Financial Overview
    • 16.3.6.4. SWOT Analysis
    • 16.3.6.5. Strategic Overview
  • 16.3.7. Samyang Holdings Corporation
    • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.7.2. Product Portfolio
    • 16.3.7.3. Financial Overview
    • 16.3.7.4. SWOT Analysis
    • 16.3.7.5. Strategic Overview
  • 16.3.8. Gedeon Richter PLC
    • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.8.2. Product Portfolio
    • 16.3.8.3. Financial Overview
    • 16.3.8.4. SWOT Analysis
    • 16.3.8.5. Strategic Overview
  • 16.3.9. AdhexPharma
    • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.9.2. Product Portfolio
    • 16.3.9.3. Financial Overview
    • 16.3.9.4. SWOT Analysis
    • 16.3.9.5. Strategic Overview
  • 16.3.10. Sparsha Pharma International Pvt. Ltd.
    • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 16.3.10.2. Product Portfolio
    • 16.3.10.3. Financial Overview
    • 16.3.10.4. SWOT Analysis
    • 16.3.10.5. Strategic Overview